GARRETT SWEET: Open Payments
NPI 1558040824 · MERIDIAN, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$230 in 10 payments from 9 companies in 2025. Trend: 2023 $196 · 2024 $716 · 2025 $230
Food & beverage: $230
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 1 | $32 |
| Procept Biorobotics Corporation | 1 | $30 |
| ABBVIE INC. | 2 | $30 |
| Sumitomo Pharma America, Inc. | 1 | $27 |
| Teleflex LLC | 1 | $27 |
| Amgen Inc. | 1 | $24 |
| Endo USA, Inc. | 1 | $24 |
| Olympus America Inc. | 1 | $22 |
| Astellas Pharma US Inc | 1 | $14 |
Products named: AQUABEAM ROBOTIC SYSTEM, ORGOVYX, UROLIFT, EVENITY, AVEED, iTIND System, BOTOX, Xtandi.
Industry payments across ID — which companies pay providers there.
